Literature DB >> 28215927

Will drug companies' price-transparency efforts fall short?

Bryant Furlow.   

Abstract

Mesh：

Year:  2017        PMID： 28215927     DOI： 10.1016/S1470-2045(17)30122-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

Review 1.  Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.

Authors:  Shan Jiang; Zhuo Chen; Tao Wu; Hui Wang
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.